News from moberg pharma A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

14 Oct, 2020, 07:27 BST Moberg Pharma intends to submit a registration application in Europe in 2021

Moberg Pharma AB (OMX: MOB) announced today its decision to request pre-submission meetings with regulatory agencies, with the goal of submitting a...


25 Jun, 2020, 07:26 BST Moberg Pharma Meets Primary Endpoint in the European Phase 3 Study

Moberg Pharma AB (OMX: MOB) announces that MOB-015 (topical terbinafine) met the primary endpoint in the European Phase 3 study including 452...


30 Sep, 2019, 17:18 BST Moberg Pharma Proposes to pay the Shareholders SEK 46.50 per Ordinary Share and Repays the MOB-015 Loan

As previously communicated, Moberg Pharma AB (publ) ("Moberg Pharma" or the "Company"), intends to propose the Annual General Meeting for the...


30 Sep, 2019, 17:15 BST Moberg Pharma and Taisho Sign Exclusive License Agreement for MOB-015 in Japan

Moberg Pharma AB (OMX: MOB) has signed an exclusive license agreement with Taisho Pharmaceutical Co., Ltd for development, registration and...


29 Mar, 2019, 21:09 GMT Moberg Pharma Completes the Divestment of the OTC-business for USD 155 million

Moberg Pharma AB (publ) ("Moberg Pharma" or the "Company") has today completed the divestment of its OTC-business (over-the-counter) to RoundTable...


11 Feb, 2019, 17:13 GMT Moberg Pharma and Bayer Sign Exclusive License Agreement for MOB-015 in Europe

Moberg Pharma AB (OMX: MOB) has signed an exclusive license agreement with Bayer for commercialization of MOB-015 in Europe. Under the agreement,...


18 Jan, 2017, 07:50 GMT Moberg Pharma Expands New Skin Retail Presence

Moberg Pharma AB (OMX: MOB) today announced that the New Skin® Spray SKU will be sold in 3,900 Walmart stores and in over 1,500 Walgreens stores....


31 Dec, 2016, 15:59 GMT Moberg Pharma Completes Acquisition of DermoPlast From Prestige Brands

Moberg Pharma AB (OMX: MOB) has now completed the previously announced acquisition of DermoPlast® from Prestige Brands, Inc pursuant to the terms...


30 Dec, 2016, 07:43 GMT Change in Number of Shares and Votes in Moberg Pharma

The number of shares and votes in Moberg Pharma AB (publ) ("Moberg Pharma") has increased by 3,122,654 in December 2016. Therefore, there are in...


20 Dec, 2016, 08:05 GMT Moberg Pharma Completes Divestment of PediaCare for $5.6 Million

Moberg Pharma AB (OMX: MOB) announces that the company has completed the divestment of the PediaCare® brand to Strides Arcolab International Limited, ...